Clinical Trial Update: Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial [Phase 3]

View source ↗

Summary

Phase 3 sub-study results on efficacy and safety of APT-1011 in adolescents with eosinophilic esophagitis completed as part of the FLUTE-2 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• APT-1011

Snippet

Sponsor: Ellodi Pharmaceuticals, LP | Conditions: Eosinophilic Esophagitis | Phase 3 | Status: COMPLETED